effects [qlco]
therapy, hormonal [topp]
Replacement [topp]
Oxidative Stress [comd]
Antioxidant [phsu]
Capacity [qnco]
postmenopausal [tmco]
Haemodialysis [topp]
Patients [podg]
Background [cnce]
Oxidative Stress [comd]
Known [qlco]
To [qlco]
pathogenesis [ftcn]
Atherosclerotic Cardiovascular Disease [dsyn]
studies [lbpr]
Hormone replacement therapy [topp]
effects [qlco]
Oxidation [moft]
Injury [inpo]
postmenopausal [tmco]
Women [popg]
Normal renal function [fndg]
Study [mnob]
Examined [fndg]
effects [qlco]
Hormone replacement therapy [topp]
Plasma [bdsu]
Malondialdehyde [orch]
Level [qlco]
Antioxidant [phsu]
Capacity [qnco]
postmenopausal [tmco]
Haemodialysis [topp]
Women [popg]
Methods [inpr]
Assigned [ftcn]
postmenopausal [tmco]
Women [popg]
Maintenance [acty]
Haemodialysis [topp]
Hormone replacement therapy [topp]
Group [idcn]
Control Group [grup]
Oral [spco]
Conjugated estrogen [horm, phsu, strd]
mg% [qnco]
Combined [qlco]
medroxyprogesterone acetate [horm, phsu, strd]
mg% [qnco]
GIVEN [cnce]
Daily [tmco]
weeks [tmco]
Hormone replacement therapy [topp]
Group [idcn]
Plasma [bdsu]
Malondialdehyde [orch]
Antioxidant [phsu]
Capacity [qnco]
Albumin [aapp, bacs]
Uric Acid [bacs, orch]
C-reactive protein [aapp, imft]
Measured [qlco]
Before [tmco]
weeks [tmco]
Start [tmco]
Medication [phsu]
Hormone replacement therapy [topp]
Group [idcn]
Control Group [grup]
Same [qlco]
Parameters [fndg]
Measured [qlco]
Hormone replacement therapy [topp]
Result [ftcn]
baseline [bodm]
Values [qlco]
Two [qnco]
Group [idcn]
Control Group [grup]
N NOS [aapp, imft]
Parameters [fndg]
Show [inpr]
Change [ftcn]
weeks [tmco]
Hormone replacement therapy [topp]
Decreased [qnco]
Malondialdehyde [orch]
mum [plnt]
mum [plnt]
P NOS [aapp, imft]
mum [plnt]
P NOS [aapp, imft]
weeks [tmco]
N NOS [aapp, imft]
Antioxidant [phsu]
Capacity [qnco]
Not [ftcn]
Changed [ftcn]
Decreased [qnco]
P NOS [aapp, imft]
weeks [tmco]
Albumin [aapp, bacs]
Uric Acid [bacs, orch]
C-reactive protein level [lbpr]
Not [ftcn]
Changed [ftcn]
Hormone replacement therapy [topp]
Conclusions [idcn]
Result [ftcn]
Suggest [idcn]
Hormone replacement therapy [topp]
Favorable [qlco]
Effect [qlco]
Oxidative Stress [comd]
postmenopausal [tmco]
Women [popg]
ESRD [dsyn]
General Population [popg]
